Fig. 6From: Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancerThe relationship between XRCC4 expression and pan-cancer immune subtypes. A in BRCA, B in HNSC, C in UCEC, D in LIHC, E in COAD, F in TGCT, G in LUAD and H in STADBack to article page